ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

IXHL Incannex Healthcare Ltd

2.55
-0.12 (-4.49%)
2024年5月3日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Incannex Healthcare Ltd IXHL NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.12 -4.49% 2.55 05:23:07
始値 安値 高値 終値 前日終値
2.70 2.5477 2.85 2.55 2.67
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1621:00GLOBEIncannex Healthcare Inc. Quarterly Update, Q1 2024
2024/2/2821:30GLOBEIncannex Announces Positive Topline Results from Phase 2..
2024/2/1622:00EDGAR2Form 8-K - Current report
2024/2/1621:30GLOBEIncannex Completes Successful Pre-IND Meeting with the FDA..
2024/2/1420:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/2/0121:30EDGAR2Form 8-K - Current report
2024/2/0121:30GLOBEClarion Clinics Open for Psychedelic-Assisted Treatments
2024/1/2506:30EDGAR2Form 8-K - Current report
2024/1/2506:05GLOBEIncannex Commences Dosing in Phase 2 Clinical Trial..
2024/1/1823:08EDGAR2Form 8-K - Current report
2024/1/1822:22GLOBEIncannex Completes Dosing and Therapy in Phase 2 “PsiGAD”..
2024/1/1721:30GLOBEIncannex Receives IRB Approval for the RePOSA Phase 2/3..
2024/1/1720:05EDGAR2Form 8-K - Current report
2023/12/2220:07EDGAR2Form 8-K - Current report
2023/12/2210:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2210:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2210:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2210:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2206:05GLOBEClarion Clinics Receives Ethics Board Endorsement for the..
2023/12/2107:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/12/0621:30GLOBEIncannex Update on IHL-42X Drug Candidate in Phase 2/3..
2023/11/3003:40GLOBEIncannex Healthcare Announces Completion of..
2023/11/1623:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1622:30GLOBEFederal Court of Australia Approves Incannex’s..
2023/11/0820:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2619:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/0820:30GLOBEIncannex Announces Participation at the H.C. Wainwright 25th..
2023/9/0819:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/0121:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/2420:30GLOBEIncannex to Prepare FDA IND Application for..
2023/8/2220:30GLOBEReview of IND Application for IHL-42X by US FDA has been..
2023/8/0821:00GLOBEClarion Clinics Begins Accepting Registrations for..
2023/8/0819:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/2820:30GLOBEIncannex Healthcare June 2023 Quarterly Activities Report..
2023/7/2620:30GLOBEIncannex Completes Positive Pre-IND Meeting with US FDA on..
2023/7/2122:09GLOBEIncannex Submits IND Application to the US FDA for IHL-42X..
2023/7/1820:40GLOBEIncannex engages Fortrea to Manage its FDA IND Opening Phase..
2023/7/1321:00GLOBEIncannex Receives HREC Approval for Phase 2 Clinical Trial..
2023/7/1319:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/1021:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/1020:30GLOBEIncannex Announces Intention to Redomicile to United States,..
2023/7/0621:42GLOBEIncannex Receives Ethics Approval for..
2023/6/2321:00GLOBEIncannex Announces Participation at the H.C. Wainwright 4th..
2023/6/1621:00GLOBEIncannex Appoints Principal Investigators for IHL-42X Phase..
2023/5/3021:00GLOBEWorld Renowned International Psychedelics Experts Join..
2023/5/1620:50GLOBEIncannex Company Presentation – Presentation of Psychennex,..
2023/5/0520:30GLOBEIncannex enters a lease for first psychedelic-assisted..

最近閲覧した銘柄

Delayed Upgrade Clock